Business
Quantum eMotion Reaches a Successful Commercialization Milestone with Its Sentry-Q Cybersecurity Platform
Montreal, Quebec--(Newsfile Corp. - August 21, 2023) - Quantum eMotion Corp . (TSXV: QNC) (OTCQB:...
About this update from Quantum Emotion Corp.
[{"type":"text","content":"Quantum eMotion Reaches a Successful Commercialization Milestone with Its Sentry-Q Cybersecurity PlatformMontreal, Quebec--(Newsfile Corp. - August 21, 2023) - Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) (\"QeM\" or the \"Company\") a pioneering force in classical and quantum cybersecurity, announces a significant milestone in its journey towards the commercialization of its cloud-based Sentry-Q platform to address the unmet cybersecurity needs of modern telemedicine and digital healthcare.Following its last Spring announcement of a revenue-sharing commercial partnership with QeM to strengthen the cybersecurity requisites of its innovative Digital Therapeutics (DTx) platform, Greybox Solutions has now been selected to implement in the Quebec healthcare system its cutting-edge solution for chronic diseases care, aiming to demonstrate enhanced patient services, experience, and overall performance. Greybox was chosen on the base of its ability to meet technical and cybersecurity requirements, showcasing their tailored patient-focused solutions. As the use of digital therapeutics becomes more widespread, the importance of cybersecurity in this context cannot be overstated. Cybersecurity is an essential component of the digital therapeutics landscape. By protecting patient data, ensuring treatment accuracy, and maintaining platform reliability, cybersecurity measures contribute to the overall safety, efficacy, and trustworthiness of digital therapeutic interventions. As the field continues to grow, investing in robust cybersecurity practices will be instrumental in realizing the full potential of digital therapeutics to transform healthcare.Pierre Berube, CEO of GreyBox, commented: \"I am thrilled by this opportunity. This marks a significant stride toward digital transformation in Quebec's healthcare system, paving the way for wider integration of digital therapies. Our DTx platform, originally developed in partnership with the Centre Hospitalier de l'Université de Montréal (CHUM) and Boehringer Ingelheim Canada, has already demonstrated clinical superiority in the field of heart failure. In addition, it will be fortified with state-of-the-art cybersecurity, seamlessly incorporating QeM's Sentry-Q cybersecurity platform to ensure the utmost protection for our patients. These two key features will establish us as one o...